T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
48 hedge funds and large institutions have $182M invested in T2 Biosystems, Inc in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 9 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
6% less funds holding
Funds holding: 51 → 48 (-3)
8% less capital invested
Capital invested by funds: $198M → $182M (-$15.8M)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$5.97M |
| 2 |
SM
Senvest Management
New York
|
+$3.09M |
| 3 |
TM
Tiger Management
New York
|
+$1.1M |
| 4 |
Goldman Sachs
New York
|
+$442K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$353K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.77M |
| 2 |
AP
AlpInvest Partners
Amsterdam,
Netherlands
|
-$1.47M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.15M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$751K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$442K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SFPM
51
Sensible Financial Planning & Management
Waltham,
Massachusetts
| $6K | – | – | – |
|
52
BlackRock
New York
| $3K | – | – | – |
|
53
First Manhattan
New York
| $2K | – | – | – |
|
|
PFG
54
Piershale Financial Group
Barrington,
Illinois
| $2K | – | – | – |
|
55
Geode Capital Management
Boston,
Massachusetts
| $987 | – | – | – |
|
|
56
Millennium Management
New York
| – | -$2.77M | -51 | Closed |
|
|
AP
57
AlpInvest Partners
Amsterdam,
Netherlands
| – | -$1.47M | -27 | Closed |
|
|
EGM
58
Espalier Global Management
New York
| – | -$342K | -6 | Closed |
|
59
Citadel Advisors
Miami,
Florida
| – | -$289K | -5 | Closed |
|
|
QSS
60
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
| – | -$272K | -5 | Closed |
|
61
Nomura Holdings
Tokyo,
Japan
| – | -$209K | -4 | Closed |
|
62
Renaissance Technologies
New York
| – | -$243K | -4 | Closed |
|
|
RI
63
RTW Investments
New York
| – | -$229K | -4 | Closed |
|
|
BJ
64
BlackRock Japan
Tokyo,
Japan
| – | -$12K | – | – |
|
65
BNP Paribas Financial Markets
Paris,
France
| – | -$21.6K | – | – |
|
|
PCM
66
Prelude Capital Management
New York
| – | -$21K | – | – |
|
TTOO Hedge Fund Activity: Q1 2016 in Review
48 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2016, worth a combined $182M — down 8% from $198M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of TTOO and 8 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 14 added.
The largest buyer was Lagoda Investment Management, adding an estimated $5.97M. The largest seller was Millennium Management, exiting entirely with an estimated $2.77M sold.
- 48 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2016, down from 51 in Q4 2015.
- Funds reported $182M of T2 Biosystems, Inc stock for Q1 2016, down 8% quarter-over-quarter.
- 8 funds opened new T2 Biosystems, Inc positions in Q1 2016 and 9 closed out, a net change of -1 holder.
- The largest T2 Biosystems, Inc buyer in Q1 2016 was Lagoda Investment Management, an estimated $5.97M added.
- The largest T2 Biosystems, Inc seller in Q1 2016 was Millennium Management, an estimated $2.77M sold.
Based on aggregated 13F filings for Q1 2016.